Akzo Nobel (AKZA NA) and Axalta (AXTA) are reportedly expected to get EU antitrust approval after offering to sell Axalta's vehicle refinish business, according to reports

Antitrust clearance conditioned on a divestiture is the standard resolution when two coatings peers with overlapping product lines combine; regulators in past episodes of this kind have consistently focused remedies on the specific segment where the merged entity would hold excessive share, here the refinish business, rather than blocking outright. The pattern in comparable deals is that approval with remedies de-risks the completion leg and compresses the spread on the target toward the offer terms, while attention shifts to the quality and price of the asset being sold, since a forced disposal of a crown-jewel unit changes the synergy math that justified the deal. What separates outcomes is whether the remedy buyer is a credible strategic or financial owner and whether the divestiture perimeter widens during the buyer review; late-stage remedies have historically been the point where timelines slip. Worth noting is the sequencing: formal clearance decisions, identification of the refinish purchaser, and any statement of objections on adjacent segments are the follow-ons that determine the closing timetable. Until the formal decision publishes, reports of expected approval remain the kind of leak that has on previous occasions proven accurate but premature by weeks.